The Ministry of Industry and Information of China announced that companies will be encouraged to accelerate vaccine production in order to ensure the production and supply of Covid-19 vaccines. According to the data of the Ministry of Industry and Information, the production processes of companies that meet large-scale production conditions such as Sinopharm and Sinovac are accelerating.
Zhang Jin, head of Sinopharm Beijing's Covid-19 inactivated vaccine project, said that the company will expand its production capacity, and that inactive vaccine production capacity will exceed 2021 billion doses by 1. In the statement of the Ministry, it was stated that 18 domestic companies are currently working to produce Covid-19 vaccines, and domestic demand can be met with further increase in inactive vaccine production capacity.
Source: China International Radio